Antibiotic Resistance Market Size, Trends, Analysis, and Outlook By Disease (Complicated Urinary Tract Infections, Clostridioides difficile Infection, Acute bacterial skin and skin structure infections, Hospital-acquired bacterial pneumonia, Community-acquired pneumonia, Complicated intra-abdominal infection, Bloodstream infection), By Pathogen, E. coli, K. pneumoniae, P. aeruginosa, S. aureus, A. baumannii, S. pneumoniae, H. influenzae, C. difficile, E. faecium), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, Others), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
The global Antibiotic Resistance market size is poised to register 5.7% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Antibiotic Resistance market across By Disease (Complicated Urinary Tract Infections, Clostridioides difficile Infection, Acute bacterial skin and skin structure infections, Hospital-acquired bacterial pneumonia, Community-acquired pneumonia, Complicated intra-abdominal infection, Bloodstream infection), By Pathogen, E. coli, K. pneumoniae, P. aeruginosa, S. aureus, A. baumannii, S. pneumoniae, H. influenzae, C. difficile, E. faecium), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, Others), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).
The antibiotic resistance market is witnessing significant growth driven by the increasing incidence of antibiotic-resistant infections, rising demand for rapid diagnostic tests, and growing focus on antibiotic stewardship programs. In 2024 and beyond, factors such as the expanding patient pool for multidrug-resistant organisms (MDROs), rising mortality rates associated with antibiotic-resistant infections, and advancements in molecular diagnostics for antibiotic susceptibility testing contribute to market expansion. Additionally, the development of new antibiotic classes and alternative treatment strategies, expansion of surveillance networks for antimicrobial resistance (AMR) monitoring, and rising investment in infection prevention and control initiatives drive market growth.
Antibiotic Resistance Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Antibiotic Resistance market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Antibiotic Resistance survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Antibiotic Resistance industry.
Key market trends defining the global Antibiotic Resistance demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Antibiotic Resistance Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Antibiotic Resistance industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Antibiotic Resistance companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Antibiotic Resistance industry
Leading Antibiotic Resistance companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Antibiotic Resistance companies.
Antibiotic Resistance Market Study- Strategic Analysis Review
The Antibiotic Resistance market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Antibiotic Resistance industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Antibiotic Resistance Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Antibiotic Resistance Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Antibiotic Resistance market segments. Similarly, Strong end-user demand is encouraging Canadian Antibiotic Resistance companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Antibiotic Resistance market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Antibiotic Resistance Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Antibiotic Resistance industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Antibiotic Resistance market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Antibiotic Resistance Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Antibiotic Resistance in Asia Pacific. In particular, China, India, and South East Asian Antibiotic Resistance markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Antibiotic Resistance Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Antibiotic Resistance Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Antibiotic Resistance market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Antibiotic Resistance.
Antibiotic Resistance Market Company Profiles
The global Antibiotic Resistance market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie, ACHAOGEN Inc, Basilea Pharmaceutica Ltd, Entasis therapeutics, Melinta Therapeutics, Merck & Co. Inc, Paratek Pharmaceuticals Inc, Seres Therapeutics, Tetraphase Pharmaceuticals, Theravance Biopharma, WOCKHARDT
Recent Antibiotic Resistance Market Developments
The global Antibiotic Resistance market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Antibiotic Resistance Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Disease
cUTI (Complicated Urinary Tract Infections)
CDI (Clostridioides difficile Infection)
ABSSSI (Acute bacterial skin and skin structure infections)
HABP (Hospital-acquired bacterial pneumonia)
CABP (Community-acquired pneumonia)
cIAI (Complicated intra-abdominal infection)
BSI (Bloodstream infection)
By Pathogen
E. coli
K. pneumoniae
P. aeruginosa
S. aureus
A. baumannii
S. pneumoniae
H. influenzae
C. difficile
E. faecium
By Drug Class
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Combination therapies
Cephalosporins
Others
By Mechanism of Action
Protein Synthesis Inhibitors
Cell Wall Synthesis Inhibitors
RNA Synthesis Inhibitors
DNA Synthesis Inhibitors
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographical Segmentation:
AbbVie
ACHAOGEN Inc
Basilea Pharmaceutica Ltd
Entasis therapeutics
Melinta Therapeutics
Merck & Co. Inc
Paratek Pharmaceuticals Inc
Seres Therapeutics
Tetraphase Pharmaceuticals
Theravance Biopharma
WOCKHARDT
Formats Available: Excel, PDF, and PPT
The antibiotic resistance market is witnessing significant growth driven by the increasing incidence of antibiotic-resistant infections, rising demand for rapid diagnostic tests, and growing focus on antibiotic stewardship programs. In 2024 and beyond, factors such as the expanding patient pool for multidrug-resistant organisms (MDROs), rising mortality rates associated with antibiotic-resistant infections, and advancements in molecular diagnostics for antibiotic susceptibility testing contribute to market expansion. Additionally, the development of new antibiotic classes and alternative treatment strategies, expansion of surveillance networks for antimicrobial resistance (AMR) monitoring, and rising investment in infection prevention and control initiatives drive market growth.
Antibiotic Resistance Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Antibiotic Resistance market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Antibiotic Resistance survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Antibiotic Resistance industry.
Key market trends defining the global Antibiotic Resistance demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Antibiotic Resistance Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Antibiotic Resistance industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Antibiotic Resistance companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Antibiotic Resistance industry
Leading Antibiotic Resistance companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Antibiotic Resistance companies.
Antibiotic Resistance Market Study- Strategic Analysis Review
The Antibiotic Resistance market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Antibiotic Resistance industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Antibiotic Resistance Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Antibiotic Resistance Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Antibiotic Resistance market segments. Similarly, Strong end-user demand is encouraging Canadian Antibiotic Resistance companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Antibiotic Resistance market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Antibiotic Resistance Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Antibiotic Resistance industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Antibiotic Resistance market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Antibiotic Resistance Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Antibiotic Resistance in Asia Pacific. In particular, China, India, and South East Asian Antibiotic Resistance markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Antibiotic Resistance Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Antibiotic Resistance Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Antibiotic Resistance market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Antibiotic Resistance.
Antibiotic Resistance Market Company Profiles
The global Antibiotic Resistance market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie, ACHAOGEN Inc, Basilea Pharmaceutica Ltd, Entasis therapeutics, Melinta Therapeutics, Merck & Co. Inc, Paratek Pharmaceuticals Inc, Seres Therapeutics, Tetraphase Pharmaceuticals, Theravance Biopharma, WOCKHARDT
Recent Antibiotic Resistance Market Developments
The global Antibiotic Resistance market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Antibiotic Resistance Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Disease
cUTI (Complicated Urinary Tract Infections)
CDI (Clostridioides difficile Infection)
ABSSSI (Acute bacterial skin and skin structure infections)
HABP (Hospital-acquired bacterial pneumonia)
CABP (Community-acquired pneumonia)
cIAI (Complicated intra-abdominal infection)
BSI (Bloodstream infection)
By Pathogen
E. coli
K. pneumoniae
P. aeruginosa
S. aureus
A. baumannii
S. pneumoniae
H. influenzae
C. difficile
E. faecium
By Drug Class
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Combination therapies
Cephalosporins
Others
By Mechanism of Action
Protein Synthesis Inhibitors
Cell Wall Synthesis Inhibitors
RNA Synthesis Inhibitors
DNA Synthesis Inhibitors
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie
ACHAOGEN Inc
Basilea Pharmaceutica Ltd
Entasis therapeutics
Melinta Therapeutics
Merck & Co. Inc
Paratek Pharmaceuticals Inc
Seres Therapeutics
Tetraphase Pharmaceuticals
Theravance Biopharma
WOCKHARDT
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Antibiotic Resistance Market Overview and Key Findings, 2024
1.2 Antibiotic Resistance Market Size and Growth Outlook, 2021- 2030
1.3 Antibiotic Resistance Market Growth Opportunities to 2030
1.4 Key Antibiotic Resistance Market Trends and Challenges
1.4.1 Antibiotic Resistance Market Drivers and Trends
1.4.2 Antibiotic Resistance Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Antibiotic Resistance Companies
2. ANTIBIOTIC RESISTANCE MARKET SIZE OUTLOOK TO 2030
2.1 Antibiotic Resistance Market Size Outlook, USD Million, 2021- 2030
2.2 Antibiotic Resistance Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ANTIBIOTIC RESISTANCE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ANTIBIOTIC RESISTANCE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
cUTI (Complicated Urinary Tract Infections)
CDI (Clostridioides difficile Infection)
ABSSSI (Acute bacterial skin and skin structure infections)
HABP (Hospital-acquired bacterial pneumonia)
CABP (Community-acquired pneumonia)
cIAI (Complicated intra-abdominal infection)
BSI (Bloodstream infection)
By Pathogen
E. coli
K. pneumoniae
P. aeruginosa
S. aureus
A. baumannii
S. pneumoniae
H. influenzae
C. difficile
E. faecium
By Drug Class
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Combination therapies
Cephalosporins
Others
By Mechanism of Action
Protein Synthesis Inhibitors
Cell Wall Synthesis Inhibitors
RNA Synthesis Inhibitors
DNA Synthesis Inhibitors
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Antibiotic Resistance Market, 2025
5.2 Asia Pacific Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Antibiotic Resistance Market, 2025
5.5 Europe Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.6 Europe Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Antibiotic Resistance Market, 2025
5.8 North America Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.9 North America Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Antibiotic Resistance Market, 2025
5.11 South America Pacific Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.12 South America Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Antibiotic Resistance Market, 2025
5.14 Middle East Africa Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Antibiotic Resistance Market Size Outlook and Revenue Growth Forecasts
6.2 US Antibiotic Resistance Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Antibiotic Resistance Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Antibiotic Resistance Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Antibiotic Resistance Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Antibiotic Resistance Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Antibiotic Resistance Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Antibiotic Resistance Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Antibiotic Resistance Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Antibiotic Resistance Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Antibiotic Resistance Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Antibiotic Resistance Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Antibiotic Resistance Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Antibiotic Resistance Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Antibiotic Resistance Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Antibiotic Resistance Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Antibiotic Resistance Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Antibiotic Resistance Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Antibiotic Resistance Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Antibiotic Resistance Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Antibiotic Resistance Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Antibiotic Resistance Industry Drivers and Opportunities
7. ANTIBIOTIC RESISTANCE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ANTIBIOTIC RESISTANCE COMPANY PROFILES
8.1 Profiles of Leading Antibiotic Resistance Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie
ACHAOGEN Inc
Basilea Pharmaceutica Ltd
Entasis therapeutics
Melinta Therapeutics
Merck & Co. Inc
Paratek Pharmaceuticals Inc
Seres Therapeutics
Tetraphase Pharmaceuticals
Theravance Biopharma
WOCKHARDT
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Antibiotic Resistance Market Overview and Key Findings, 2024
1.2 Antibiotic Resistance Market Size and Growth Outlook, 2021- 2030
1.3 Antibiotic Resistance Market Growth Opportunities to 2030
1.4 Key Antibiotic Resistance Market Trends and Challenges
1.4.1 Antibiotic Resistance Market Drivers and Trends
1.4.2 Antibiotic Resistance Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Antibiotic Resistance Companies
2. ANTIBIOTIC RESISTANCE MARKET SIZE OUTLOOK TO 2030
2.1 Antibiotic Resistance Market Size Outlook, USD Million, 2021- 2030
2.2 Antibiotic Resistance Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ANTIBIOTIC RESISTANCE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ANTIBIOTIC RESISTANCE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
cUTI (Complicated Urinary Tract Infections)
CDI (Clostridioides difficile Infection)
ABSSSI (Acute bacterial skin and skin structure infections)
HABP (Hospital-acquired bacterial pneumonia)
CABP (Community-acquired pneumonia)
cIAI (Complicated intra-abdominal infection)
BSI (Bloodstream infection)
By Pathogen
E. coli
K. pneumoniae
P. aeruginosa
S. aureus
A. baumannii
S. pneumoniae
H. influenzae
C. difficile
E. faecium
By Drug Class
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Combination therapies
Cephalosporins
Others
By Mechanism of Action
Protein Synthesis Inhibitors
Cell Wall Synthesis Inhibitors
RNA Synthesis Inhibitors
DNA Synthesis Inhibitors
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Antibiotic Resistance Market, 2025
5.2 Asia Pacific Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Antibiotic Resistance Market, 2025
5.5 Europe Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.6 Europe Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Antibiotic Resistance Market, 2025
5.8 North America Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.9 North America Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Antibiotic Resistance Market, 2025
5.11 South America Pacific Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.12 South America Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Antibiotic Resistance Market, 2025
5.14 Middle East Africa Antibiotic Resistance Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Antibiotic Resistance Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Antibiotic Resistance Market Size Outlook and Revenue Growth Forecasts
6.2 US Antibiotic Resistance Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Antibiotic Resistance Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Antibiotic Resistance Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Antibiotic Resistance Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Antibiotic Resistance Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Antibiotic Resistance Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Antibiotic Resistance Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Antibiotic Resistance Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Antibiotic Resistance Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Antibiotic Resistance Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Antibiotic Resistance Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Antibiotic Resistance Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Antibiotic Resistance Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Antibiotic Resistance Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Antibiotic Resistance Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Antibiotic Resistance Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Antibiotic Resistance Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Antibiotic Resistance Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Antibiotic Resistance Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Antibiotic Resistance Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Antibiotic Resistance Industry Drivers and Opportunities
7. ANTIBIOTIC RESISTANCE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ANTIBIOTIC RESISTANCE COMPANY PROFILES
8.1 Profiles of Leading Antibiotic Resistance Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie
ACHAOGEN Inc
Basilea Pharmaceutica Ltd
Entasis therapeutics
Melinta Therapeutics
Merck & Co. Inc
Paratek Pharmaceuticals Inc
Seres Therapeutics
Tetraphase Pharmaceuticals
Theravance Biopharma
WOCKHARDT
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
